Quality of Life in Vitiligo Patients at H. Adam Malik General Hospital Medan, Indonesia by Jusuf, Nelva Karmila et al.
Sumatera Medical Journal (SUMEJ) Vol. 01, No. 01, 2018 | 41 - 47 
 
SUMEJ  
Sumatera Medical Journal 
 
 
 
*Corresponding author at: Faculty of Medicine, Jalan Doktor Mansyur No.5 Kampus USU Padang Bulan, Medan, 
Sumatera Utara 20155 
 
 
Copyright © 2018 Published by Talenta Publisher, ISSN: 2622-9234 e-ISSN: 2622-1357 
Journal Homepage: http://smj.usu.ac.id 
Quality of Life in Vitiligo Patients at H. Adam Malik 
General Hospital Medan, Indonesia 
Nelva Karmila Jusuf 1*, Imam Budi Puta2, Dina Rizki Utami3 
1,2Departement of Dermatology and Venereology Faculty of Medicine, Universitas Sumatera Utara 
3Postgraduate of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara 
 
 
Abstract. Vitiligo is an acquired depigmenting skin disorder that can affect the patients’ 
quality of life (QOL). The aim of this study was to evaluate the QOL in patients with vitiligo. 
The methods of his study included 30 patients with vitiligo. All the patients filled out 
questionnaires Skindex-29. Data were compiled and analyzed statistically. The results: 
showed among the 30 vitiligo patients, 73,3 % were women and 26,7 % were men.  Mean 
age of patients were 40.53 ± 12. 91 years old.  The mean duration of vitiligo was 9.07 ± 7.643 
years. The mean total Skindex-29 score of the subjects was 24.68 ± 7,72. There was 
significant difference according to age’s group (p = 0,035) and sex (p = 0,01) but there is no 
significant difference according to duration of disease’s group (p = 0,582). The Conclusion 
of this research showed that vitiligo has a significant effect on the patients’ QOL. It seems 
counselling is needed as part of treatment in vitiligo patients. 
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Abstrak. Vitiligo adalah gangguan kulit depligasi yang dapat mempengaruhi kualitas hidup 
pasien (QOL). Tujuan dari penelitian ini adalah untuk mengevaluasi kualitas hidup pada 
pasien dengan vitiligo. Metode penelitian ini termasuk 30 pasien dengan vitiligo. Semua 
pasien mengisi kuesioner Skindex-29. Data dikumpulkan dan dianalisis secara statistik. 
Hasil dari penelitian ini menunjukkan di antara 30 pasien vitiligo, 73,3% adalah wanita dan 
26,7% adalah laki-laki. Usia rata-rata pasien adalah 40,53 ± 12. 91 tahun. Durasi rata-rata 
vitiligo adalah 9,07 ± 7,643 tahun. Jumlah total skor Skindex-29 subjek adalah 24,68 ± 7,72. 
Ada perbedaan yang signifikan menurut kelompok usia (p = 0,035) dan jenis kelamin 
(p=0,01) tetapi tidak ada perbedaan yang signifikan menurut durasi kelompok penyakit 
(p=0,582). Kesimpulan dari penelitian ini menunjukkan bahwa vitiligo memiliki efek yang 
signifikan pada kualitas hidup pasien. Tampaknya konseling diperlukan sebagai bagian dari 
perawatan pada pasien vitiligo. 
Kata Kunci: Vertiligo, Kualitas Hidup, Skindex-29 
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1. Introduction 
A healthy normal skin is essential for a person's physical and mental well being. It is an important 
aspect of their sexual attractiveness, a sense of well being and a sense of self confidence [1]. 
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Vitiligo is a common condition seen in a dermatology office, which has a variety of comorbidities. 
Worldwide, the prevalence of vitiligo ranges from 0.4 to 2.0 %, with regions of greater or lesser 
prevalence [2]. Jusuf and Meher based on medical records found in 2012 total vitiligo patients 
were 18,09% of total visits in Cosmetic Division of Outpatient Dermatology and Venereology 
Clinic in H. Adam Malik General Hospital Medan, in 2013 were 9,21%, 2014 were 8,53% and 
2015 were 8,45% [3]. Most studies demonstrate slightly greater prevalence in females [2]. Vitiligo 
is a common depigmenting skin disorder, characterized by acquired, idiopathic, progressive, 
circumscribed hypomelanosis of the skin and hair, with total absence of melanocytes 
microscopically [4]. Vitiligo is an important skin disease having major impact on quality of life 
of patients, many of whom feel distressed and stigmatized by their condition [1]. The psychosocial 
aspects of vitiligo can be described by stress as a potential cause or effect of the disease, the 
anxiety or depression of vitiligo patients, or the impact of vitiligo on patient quality of life [5]. In 
a research conducted by Hamdani and Jusuf found pigmentation disorder on face were greatly 
affecting (54,0%) quality of life in subjects at 21 Posyandu in Medan Labuhan [6]. 
 
2. Methodology 
This Patient with confirmed diagnosis of vitiligo were included in this study. Our sampling 
method was consecutive sampling. Inclusion criteria were diagnosis of vitiligo by a dermatologist 
and 18 years or above. Exclusion criteria included diagnosis of skin diseases other than vitiligo, 
other chronic disease or any conditions that might have an effect on QOL, and apparent disability. 
The study was conducted in the Dermatology Outpatient Clinic of H. Adam Malik General 
Hospital Medan, Indonesia from June 2016 to September 2016. Those who were referred to the 
clinic and met the eligibility criteria were recruited. Each subject was explained about the study 
and asked to answer the questions in Skindex-29. This tool inquired about how often (never, 
rarely, sometimes, often, all the time) during the previous 4 weeks the patient experienced the 
effect described in each item. Seven items address the symptoms domain, 10 items the emotional 
domain, and 12 items the functioning domain. All responses are transformed to a linear scale of 
100, varying from 0 (no effect) to 100 (effect experienced all the time). Skindex scores are 
reported as three scale scores, corresponding to the three domains; a scale score is the average of 
a patient’s responses to items in a given domain [7]. All data from subjects then were analyzed 
statistically. 
 
3. Results 
Among the 30 vitiligo patients, 8 patients were men and 22 were women. Most patients were 40-
49 years old (40%) with mean age was 40.53 ± 12. 91 years old. 40% of participants had vitiligo 
for 1-5 years with mean duration of vitiligo was 9.07 ± 7.643 years. Most subjects were working 
as private employee and finishing high school (Table 1). Based on categorization of total scores, 
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most patients were in moderately affected category (70%) (Table 2). The mean total skindex-29 
score of the subjects was 24.68 ± 7,72 (Table 3). There is significant difference according to age 
(p = 0,035) and sex (p = 0,01) but there is no significant difference according to duration of disease 
(p = 0,582). According to age category, the highest mean total score was found in <20 years old 
group (35,00 ± 0,00) and based on gender, female attained higher mean score  ( 27,13 ± 7,55 ) 
than male (17,95 ± 2,31 ) (Table 4) . 
 
Table 1. Distribution of Subjects Based on Demographic and Clinical Characteristics 
 
Variable 
Age (years old) 
n % 
<20 1 3,3 
20- 29  6 20 
30- 39  18 36 
50- 59 years 16 32 
60- 69 years 4 8 
70- 79 years 1 2 
Sex   
Female 22 73,3 
Male 8 26,7 
Education   
Elementary 3 10 
Junior high school 2 6,7 
Senior high school 14 46,7 
University 11 36,7 
 
Occupation 
  
Civil Officer 4 13,3 
Enterprenuer 7 23,3 
Private employee 11 36,7 
Unemployment 12 24 
 
Duration of disease (years) 
  
1-5 12 40 
6-10 6 20 
11-15 7 23,3 
16-20 4 13,3 
>20 1 3,3 
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Table 2. Distribution of 
Subject Based on Total Skindex-
29 Score Categorization 
 
 
 
 
Distribution quality of life scores in this study showed 38 (76%) subjects had a very high quality 
of life and 12 (24%) subjects had a high quality of life and we didn’t find a moderate or low 
quality of life score in all subjects (Table 2), furthermore based on the characteristics of the skin 
tag lesions we also didn’t find a significant difference in the quality of life score from all subject 
(Table 4). 
Table 3. Total Score of Skindex-29 
 n Minimum Maximum Mean Std. 
Deviation 
 
Total 
Score 
30 16.70 35.00 24.68
00 
7.7224  
 
Table 4. Distribution Category of Quality of Life  
Total Score Category n % 
<5 Very little 0 0 
6-17  Mild 9 30 
18-36  Moderate 21 70 
≥37 Severe 0 0 
Variable Mean of total score ± SD P 
Sex   
Male  17,95 ± 2,31 0,001 
Female  27,13 ± 7,55  
Age (years old)   
<20 35,00 ± 0,00  
20-29 31,95±7,47  
30-39 21,70±0,00  
40-49 20,84±5,18 0,035 
50-59 16,70±9,15  
≥60 24,68±0,00  
Duration of 
Disease (years) 
  
1-5 23,64± 7,69  
6-10 23,08± 6,17  
11-15 25,97± 8,69 0,582 
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4. Discussion 
Vitiligo considerably influences the psychological well-being of patients. Disease-induced 
disfigurement can cause patients to experience a high level of stigmatization, which can lead to 
psychosocial stresses and negative impacts on quality of life (QOL) [8]. Vitiligo is a multi-
factorial pigmentary skin disorder. Recently, the importance of emotional and psychological 
issues is proposed in incidence, progression, relapse and remission of vitiligo. There are limited 
studies conducted in developing countries, which assess life quality of patients with vitiligo [9]. 
Kim et al in Korea conducted a study regarding the impact of vitiligo in patient’ life with similar 
tool. This study was involving one hundred and thirty-three vitiligo patients and 112 patients with 
mild skin disorders. They found the symptom scale of Skindex-29 was significantly lower in 
vitiligo patients than in controls, but the function scale and the emotion scale were significantly 
higher in the vitiligo group than in controls. However, the difference in function scales between 
groups was significant in female patients, but not in male patients. Several clinical profiles, such 
as duration of disease, severity scores and previous history of treatments, showed close 
correlations with the function scale. Family history of vitiligo, Köebner phenomenon, patients’ 
perspectives on disease prognosis, and discordance of the severity scores between physicians and 
patients also influenced the Skindex-29 subscales differently. In their conclusion, the study 
suggests that patients with vitiligo were highly affected in the functional and emotional aspects 
of QOL, with some sex differences and perhaps various clinical features may play an important 
role in the QOL of vitiligo patients [8] 
Study by Ghaderi and Saadatjo in Iran involved 70 patients with vitiligo. All the patients filled 
out two questionnaires: Short Form 36 (SF-36) and Dermatology Life Quality Index (DLQI).  The 
mean score of patients with vitiligo on DLQI scale was 8.40 ± 5.76 (range, 0-23). Although males 
scores on SF-36 scale was higher than females, the difference was not statistically significant. 
With regard to age, the mean total score of SF-36 indicated insignificant differences among age 
groups. Their findings showed that vitiligo has a significant effect on the patients’ QOL [10]. 
Hedayat et al conducted a study on 25 patients as a pilot and another 173 patients as the main 
study group, in Razi Hospital, Tehran, Iran, 2013–2014. Persian version of Vitiligo Quality of 
Life index (VitiQoL) was developed with backward-forward method. The Vitiligo Area and Score 
Index (VASI), VitiQoL, and their relationship, demographic and clinical characteristic of patients 
were measured. The Mean and standard deviation of the VitiQoL score was 30.5 ± 14.5 (range 
0–60 in Persian version). They found a significant relationship between VASI score and VitiQoL 
(p = 0.015, r = 0.187. Based on behavior factor, female patients had poorer quality of life (p = 
0.02). Concomitant psychiatric problems, e.g. anxiety and depression, were not associated with 
QOL; however, they were near to being meaning (p =0.06, r =0.14) [9]. 
16-20 28,68±8,83  
≥20 16,70±0,00  
Sumatera Medical Journal (SUMEJ) Vol. 01, No. 01, 2018  46                                                                                                                                                                         
 
A study by Karia et al tried to determine the psychiatric morbidity and the QOL in patients 
suffering from vitiligo and to determine the factors related with psychiatric morbidity and those 
affecting the QOL in vitiligo patients. 50 patients of age range 18 – 65 years with disease duration 
of 1-26 years attending the vitiligo clinic in dermatology outpatient department of a tertiary care 
hospital were included and 50 persons with no dermatological or diagnosed psychiatric illness 
accompanying them served as control group. They found 30% patients in vitiligo group suffered 
from psychiatric disorder, depression was present in 20% of patients and 8% had anxiety disorder. 
That it was found that vitiligo patients had more psychiatric comorbidities as compared to control 
group and it had bearing on their quality of life too [11]. 
Vitiligo is an acquired depigmentary skin disorder characterized by white macules on the skin 
associated with social stigma. Vitiligo has major impact on the quality of life due its high cosmetic 
value, chronic nature of disease and long term ineffective treatments. Vitiligo patients suffer from 
low self-esteem and poor body image that affects their emotional and psychological well-being. 
To investigate quality of life of v itiligo patients, psychological impact of unpredictable course of 
disease and long term treatment among South Indian population Mateen et al conducted a study 
involving a total of 155 vitiligo patients who were undertaking treatment in dermatology clinic at 
the Central Research Institute of Unani Medicine. They found patients with vitiligo averaged at 
about 27.4% of maximum psychological impairment as measured by the Dermatology Quality of 
Life Index (DQLI) summary score. Disability in patients was highest in treatment category with 
54.6% of impairment followed by symptoms and feelings (41.83%). Dark skin, unmarried, slow 
responders to the treatment and those having chronicity more than 5 years showed worse quality 
of life and had 70%, 61%, 62%and 76.5% of impairment in the treatment front of DLQI 
respectively when compared to light skin (50%), married (52.5%), rapid responders (26%) and 
chronicity less than 5 years (52%). There was no significant difference in the quality of life 
between male and female Vitiligo patients. Their results show that vitiligo patients suffer in all 
aspects of life especially in treatment aspect of DLQI and psychological impairment strongly 
affects the social well-being of vitiligo patients [12]. 
A study group comprised of 54 subjects with vitiligo, 57 with psoriasis and 57 unaffected controls 
with all subjects were examined and interviewed using the DLQI and Emotional State 
questionnaires. They found total mean DLQI score in vitiligo was 4.7, compared with 0.6 in 
healthy controls (p < 0.001) and 13.1 in psoriasis (p < 0.001). In vitiligo, females experienced a 
greater impact on feelings and men experienced a greater impact on relationships. Lower quality 
of life in vitiligo was associated with active stage of the disease, extension of pigment loss, 
depigmentation on the hands, and earlier onset of disease. The results demonstrate that vitiligo 
has less impact on quality of life than psoriasis. This case-control study of fair-skinned subjects 
demonstrates the low level of disease-related impairment in QOL in vitiligo compared with the 
severe impairment in QOL in psoriasis [13] 
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In our study, we found the mean total skindex-29 score of the subjects was 24.68 ± 7,72. 
According to Nijsten categorization, it fell on moderate category [14]. There is significant 
difference according to age’s group (p = 0,035) and sex (p = 0,01) but there is no significant 
difference according to duration of disease (p = 0,582). This might be because women and 
younger people are more concern in appearance than men and older ones. 
5. Conclusion 
Vitiligo can affect patient’s quality of life because cosmetically disturbing. Counselling may be 
needed as part of treatment to improve subjects and their families’ attitude toward this disease. 
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